Eloxx Pharmaceuticals(ELOX)
$13.01+0.11 (+0.85%)
ELOX
Eloxx Pharmaceuticals stock forecast
$13.01
At close:+0.11 (+0.85%)
Want to see ELOX full AI Analyst Report?
Eloxx Pharmaceuticals (ELOX) Stock Forecast & Price Target
308 Followers
ELOX Analyst Ratings
Strong Buy
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Eloxx Pharmaceuticals in the past 3 months
ELOX Stock 12 Month Forecast
Average Price Target
$36.67▲(181.83% Upside)Based on 4 Wall Street analysts offering 12 month price targets for Eloxx Pharmaceuticals in the last 3 months. The average price target is $36.67 with a high forecast of $40.00 and a low forecast of $32.00. The average price target represents a 181.83% change from the last price of $13.01.
Past 12 Months12 Month ForecastJan2026Oct2026
High$40.00
Average$36.67
Low$32.00
Highest Price TargetHighest$40.00Average Price Target$36.67Lowest Price TargetLowest$32.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Vamil Divan | Guggenheim | $43→$40 | buy | 207.46%Upside | Reiterated | 10/27/26 | ||
| Yanni Souroutzidis | Cantor Fitzgerald | ― | buy | ― | Initiated | 10/15/26 | ||
| Joseph Schwartz | Leerink Partners | $32 | buy | 145.96%Upside | Initiated | 09/18/26 | ||
| Dev Prasad | Lucid Capital | $38 | buy | 192.08%Upside | Initiated | 08/20/26 | ||
| Rami Katkhuda | LifeSci Capital | $40 | buy | 207.46%Upside | Reiterated | 08/12/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Vamil DivanGuggenheim | BuyReiterated$43→$40 | 10/27/26 | 207.46%Upside | ||
| Yanni SouroutzidisCantor Fitzgerald | BuyInitiated | 10/15/26 | ― | ||
| Joseph SchwartzLeerink Partners | BuyInitiated$32 | 09/18/26 | 145.96%Upside | ||
| Dev PrasadLucid Capital | BuyInitiated$38 | 08/20/26 | 192.08%Upside | ||
| Rami KatkhudaLifeSci Capital | BuyReiterated$40 | 08/12/26 | 207.46%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Eloxx Pharmaceuticals
3 Months
Success Rate1/2 ratings generated profit
50%
Average Return
-12.00%
Copying Rami Katkhuda's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -12.00% per trade.
1 Year
Success Rate1/2 ratings generated profit
50%
Average Return
-12.80%
Copying Rami Katkhuda's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -12.80% per trade.
2 Years
Success Rate1/2 ratings generated profit
50%
Average Return
-12.80%
Copying Rami Katkhuda's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -12.80% per trade.
ELOX Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 5 | 6 | 5 | 2 |
| Buy | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 5 | 6 | 6 | 3 |
In the current month, ELOX has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ELOX average Analyst price target in the past 3 months is 36.67.
ELOX Financial Forecast
Consensus$0.00
ELOX Sales Forecast
Next quarter’s sales forecast for ELOX is $0 with a range of ― to ―. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
ELOX Stock Forecast FAQ
What is ELOX’s average 12-month price target, according to analysts?
Based on analyst ratings, Eloxx Pharmaceuticals’s 12-month average price target is $36.67.
What is ELOX’s upside potential, based on the analysts’ average price target?
Eloxx Pharmaceuticals has 181.83% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ELOX a Buy, Sell or Hold?
Eloxx Pharmaceuticals has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Eloxx Pharmaceuticals’s price target?
The average price target for Eloxx Pharmaceuticals is $36.67. This is based on 4 12-month price targets, issued in the past 3 months. The highest analyst price target is $40.00, the lowest forecast is $32.00. The average price target represents a 181.83% increase from the current price of $13.01.
What do analysts say about Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of ELOX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
